← Back to Search

Stress Management Program for Caregivers of Dementia Patients (MASC Trial)

N/A
Waitlist Available
Led By Christine S Ritchie, MD, MSPH
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (6-8 weeks post baseline)
Awards & highlights

MASC Trial Summary

This trial tests a program to help caregivers manage stress from taking care of someone with Alzheimer's or other dementias. It teaches mindfulness, compassion and behavioral management skills.

Who is the study for?
This trial is for adults over 18 who speak English and have been unpaid caregivers to someone with Alzheimer's or dementia for at least 6 months, providing an average of 4 hours of care daily. They must be experiencing stress from caregiving, live with the care recipient, and have dealt with challenging behaviors recently.Check my eligibility
What is being tested?
The MASC program is being tested to see if it can reduce stress in caregivers. It includes mindfulness and self-compassion training, behavioral management skills, psychoeducation, and group practice sessions aimed at integrating these skills into their caregiving tasks.See study design
What are the potential side effects?
Since MASC involves psychological support techniques rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing personal experiences or applying new coping strategies.

MASC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (6-8 weeks post baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (6-8 weeks post baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of Assessments
Feasibility of Quantitative Measures
Feasibility of Recruitment
Other outcome measures
Adherence to Home Practice
Applied Mindfulness Process Scale
Caregiver self-efficacy
+18 more

MASC Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
The intervention arm will be comprised of: Six Virtual Group Sessions. The sessions will teach mindfulness, self-compassion and behavioral management skills. At Home Practice. After each group session, participants will have the opportunity to integrate the practices learned into their everyday life.

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,005,094 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,335 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,559 Total Patients Enrolled

Media Library

MASC Clinical Trial Eligibility Overview. Trial Name: NCT05847153 — N/A
Alzheimer's Dementia Research Study Groups: Intervention
Alzheimer's Dementia Clinical Trial 2023: MASC Highlights & Side Effects. Trial Name: NCT05847153 — N/A
MASC 2023 Treatment Timeline for Medical Study. Trial Name: NCT05847153 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial have available slots for participants?

"As revealed by clinicaltrials.gov, the original posting date of this medical trial was on May 1st 2023 with a subsequent edit on April 26th 2023; however, it no longer appears to be recruiting patients at present moment. Despite that, there remains 761 other trials actively looking for participants right now."

Answered by AI
~13 spots leftby Apr 2025